BioSpace News Archive

Transparency Market Research has published a new report on the endoscopic vessel harvesting systems market.

Demand for chromatography data systems in various research and laboratory operations has risen exponentially in last two decades owing to the benefits such as smooth and hassle-free laboratory operations.

Since they are scrutinized thoroughly before approvals and monitored in a highly controlled manner, owing to their sheer implications as they are implanted into the body – the market for active implantable medical devices has always been confined within a few players who have the technological expertise to abide by the stringent regulations.

Masimo announced that in a study recently published in the Journal of Tropical Pediatrics, researchers evaluating Masimo SpHb® on neonatal patients concluded that the technology “offers reliable Hb [hemoglobin] values, which are comparable with the more traditional tHb [invasive venous blood sampling].”

Expands Aegea Biotechnologies’ Intellectual Property for Methods of Detecting Rare Genetic Events and for Methods to Improve PCR Amplification Reactions; Applicable to Coronavirus (COVID-19) Molecular Diagnostic Testing

Cure Alzheimer’s Fund has been presented with $9000 by Lt. Ralph Blight representing the International Association of Fire Fighters Local 792 in Quincy, Massachusetts.

Johnson & Johnson to acquire Momenta for $52.50 per share in cash, representing a total equity value of $6.5 billion and a 70% premium to Momenta’s closing price on August 18, 2020

Eagle Pharmaceuticals, Inc. announced that preclinical research on dantrolene sodium was published today in the peer-reviewed Journal of Alzheimer’s Disease.1 The article reported results from an academic-based study that demonstrated dantrolene sodium administered intranasally improved both memory and cognition in a mouse model of Alzheimer’s disease.

Smart infusion pumps are medical devices used to control and deliver doses of medication by intravenous route. These devices enable physicians to deliver the correct dose without constant supervision. It allows doctors and nurses to treat patients with minimal exposure to infection.

Sirolimus, also known by its USAN-assigned generic name rapamycin, has gained traction in the medical and healthcare industries for its outstanding antitumor and immunosuppressive activities.